Tengfei Zhou
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Liver physiology and pathology 4
- Cancer Research top 5%
- Biomaterials top 5%
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 4
- Urology top 5%
-
- Acute Ischemic Stroke Management 16
-
- Cerebrovascular and Carotid Artery Diseases 9
-
- Venous Thromboembolism Diagnosis and Management 7
-
- Stroke Rehabilitation and Recovery 6
-
- Traumatic Brain Injury and Neurovascular Disturbances 5
- Co-authors
- Yunfeng LinShiyu LinSirong ShiTaoran TianXiaoxiao CaiTao ZhangJin DingWen Sun
- Journals
- SHILAP Revista de lepidopterología (4 papers)Hepatology (1 paper)Chemical Communications (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Tengfei Zhou
57 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 114
- Hepatology 325
- Cancer Research 393
- Biomaterials 195
- Molecular Biology 855
- Urology 71
Countries citing papers authored by Tengfei Zhou
This map shows the geographic impact of Tengfei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tengfei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tengfei Zhou more than expected).
Fields of papers citing papers by Tengfei Zhou
This network shows the impact of papers produced by Tengfei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tengfei Zhou. The network helps show where Tengfei Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tengfei Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 9 | |
| 11 | 2020 | 100 | |
| 12 | 2019 | 60 | |
| 13 | 2019 | 97 | |
| 14 | 2019 | 20 | |
| 15 | 2018 | 9 | |
| 16 | 2018 | 39 | |
| 17 | 2018 | 22 | |
| 18 | 2017 | 181 | |
| 19 | 2017 | 104 | |
| 20 | 2017 | 49 |
About Tengfei Zhou
Tengfei Zhou is a scholar working on Internal Medicine, Hepatology and Rehabilitation, having authored 58 papers that have together received 2.0k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (16 papers), Cerebrovascular and Carotid Artery Diseases (9 papers), Venous Thromboembolism Diagnosis and Management (7 papers), Stroke Rehabilitation and Recovery (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Traumatic Brain Injury and Neurovascular Disturbances (5 papers), Liver physiology and pathology (4 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Hepatology (325 citations), Cancer Research (393 citations) and Biomaterials (195 citations). Tengfei Zhou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yunfeng Lin, Shiyu Lin, Sirong Shi, Taoran Tian, Xiaoxiao Cai, Tao Zhang, Jin Ding, Wen Sun, Zhuo Cheng and Daimin Xiang. Their work appears in journals such as SHILAP Revista de lepidopterología, Hepatology and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.